Cartesian Therapeutics
RNAC
RNAC
84 hedge funds and large institutions have $63.3M invested in Cartesian Therapeutics in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 33 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
59% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 17
63% less call options, than puts
Call options by funds: $18K | Put options by funds: $48K
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
84
Holding in Top 10
–
Calls
$18K
Puts
$48K
Top Buyers
| 1 | +$3.15M | |
| 2 | +$937K | |
| 3 | +$473K | |
| 4 |
Renaissance Technologies
New York
|
+$453K |
| 5 |
Citigroup
New York
|
+$411K |
Top Sellers
| 1 | -$4.53M | |
| 2 | -$1.17M | |
| 3 | -$944K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$914K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$903K |